BORTEZOMIB
NDC 70771-1708, BORTEZOMIB, injection, powder, lyophilized, for solution, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1708
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1708 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB1 mg/mL
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1708-1 | 70771170801 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70771-1708-1) / 3.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/582c7c0d-fa25-4586-8157-a1e2653d72d9
Use it
Look up 70771-1708 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1708 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1708. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.